Anti-inflammation analgesic preparation

Abstract

The present invention is concerned with an anti-inflammation analgesic preparation which contains a specific 3-0-substituted ascorbic acid as an active ingredient, shows excellent anti-inflammation analgesic effects and is excellent in shelf life, safety to a skin and endermic absorptivity of the active ingredient.

Description

[0001] The present invention relates to an anti-inflammation analgesic preparation. More specifically, it relates to an anti-inflammation analgesic preparation which exhibits an excellent anti-inflammation analgesic effect on pains involving a swelling of a muscle, a joint or a bone and a fatigue involving lassitude and which is excellent in a shelf life, safety to a skin and endermic absorptivity of an effective ingredient.TECHNICAL BACKGROUND[0002] It has been found that a cyclooxygenase inhibitor is useful in an anti-inflammation analgesic preparation, and since then, a variety of anti-inflammation analgesic preparations containing a cyclooxygenase inhibitor have been proposed. At present, however, on the basis of any cyclooxygenase inhibitor, there has been obtained no satisfactory anti-inflammation analgesic preparation which is free from side effects and useful against lumbago, bruise, sprain, stiff shoulder, arthralgia, myalgia, a swelling and a pain after muscle fatigue or b...

AI Technical Summary

Problems solved by technology

At present, however, on the basis of any cyclooxygenase inhibitor, there has been obtained no satisfactory anti-inflammation analgesic preparation which is free from side effects and useful against lumbago, bruise, sprain, stiff shoulder, arthralgia, myalgia, a swelling and a pain after muscle fatigue or bone fracture, shoulder periarthritis, tendon-thecitis, peritendinitis, inflammation of lateral epicondyle of humerus, a swelling after injury, an ache, a swelling and a pain from rheumatism or osteoarthritis and a pain and fatigue of a leg and loins from excess exercise or labor.

However, there has been completed no technique to utilize ascorbic acid in an anti-inflammation analgesic preparation, since ascorbic acid is readily decomposed upon contact to light, heat, water and metal ion or has a problem on endermic absorptivity.

However, a typical cyclooxygenase inhibitor, indomethacin, fails to satisfy an expectation regardless of whether it is orally administered or endermicly applied.

However, they are not satisfactory since they are recognized not only to have side effects such as disorders on a stomach or duodenum but also to have side effects such as rubefaction, itching, eruption, irritation and the like.

While it has been already pointed out that an ascorbic acid has an anti-inflammation analgesic effect, there is no example of practical use thereof for a reason that it is poor in stability, safety and endermic absorptivity as described above.

When the above amount is less than 0.01% by weight, it is difficult to obtain the effect.

When it exceeds 50% by weight, undesirably, no further effect corresponding to an additional content can be observed.

Images